Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Li

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
JCO Global Oncology|January 6, 2021
Cross-Sectional International Survey to Determine the Educational Interests of Spanish-Speaking Latin American Radiation OncologistsRaymond B Mailhot Vega, Dolores De La Mata, Beatriz Amendola, et al.
Acta Biomaterialia|March 26, 2013
Synovial stem cells and their responses to the porosity of microfibrous scaffoldBenjamin Li-Ping Lee, Zhenyu Tang, Aijun Wang, et al.
Journal of the American College of Cardiology|May 11, 2019
Estimated Long-Term Survival With EplerenoneSusan Stienen, João Pedro Ferreira, John Vincent, et al.
The Oncologist|May 7, 2026
Real-world treatment durations, subsequent treatments, and switching of CDK4/6 inhibitors among patients with HR+/HER2- metastatic breast cancerAdam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 3, 2014
Validation of the immunochromatographic strip for α-thalassemia screening: a multicenter studyPranee Winichagoon, Pornnapa Kumpan, Paula Holmes, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2025
Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort studyDipesh Uprety, Devin Abrahami, Zachary A Marcum, et al.
Pharmacotherapy|September 3, 2021
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non-ST segment elevation myocardial infarction: A phase Ib/IIa studyBo Zheng, Jianping Li, Jie Jiang, et al.
Clinical and Translational Gastroenterology|February 5, 2016
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel SyndromeLauren K Schwartz, Stephen J D O'Keefe, Ken Fujioka, et al.
Advances in Therapy|November 1, 2025
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health AdministrationStephen J Freedland, Krishnan Ramaswamy, Abhishek Kavati, et al.
Cancer Medicine|March 27, 2025
Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast CancerAdam M Brufsky, Rickard Sandin, Stella Stergiopoulos, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
JCO Global Oncology|January 6, 2021
Cross-Sectional International Survey to Determine the Educational Interests of Spanish-Speaking Latin American Radiation OncologistsRaymond B Mailhot Vega, Dolores De La Mata, Beatriz Amendola, et al.
Acta Biomaterialia|March 26, 2013
Synovial stem cells and their responses to the porosity of microfibrous scaffoldBenjamin Li-Ping Lee, Zhenyu Tang, Aijun Wang, et al.
Journal of the American College of Cardiology|May 11, 2019
Estimated Long-Term Survival With EplerenoneSusan Stienen, João Pedro Ferreira, John Vincent, et al.
The Oncologist|May 7, 2026
Real-world treatment durations, subsequent treatments, and switching of CDK4/6 inhibitors among patients with HR+/HER2- metastatic breast cancerAdam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 3, 2014
Validation of the immunochromatographic strip for α-thalassemia screening: a multicenter studyPranee Winichagoon, Pornnapa Kumpan, Paula Holmes, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2025
Brain metastases and mortality in patients with ALK + metastatic non-small cell lung cancer treated with second-generation ALK tyrosine kinase inhibitors as first-line targeted therapies: An observational cohort studyDipesh Uprety, Devin Abrahami, Zachary A Marcum, et al.
Pharmacotherapy|September 3, 2021
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non-ST segment elevation myocardial infarction: A phase Ib/IIa studyBo Zheng, Jianping Li, Jie Jiang, et al.
Clinical and Translational Gastroenterology|February 5, 2016
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel SyndromeLauren K Schwartz, Stephen J D O'Keefe, Ken Fujioka, et al.
Advances in Therapy|November 1, 2025
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health AdministrationStephen J Freedland, Krishnan Ramaswamy, Abhishek Kavati, et al.
Cancer Medicine|March 27, 2025
Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2- Metastatic Breast CancerAdam M Brufsky, Rickard Sandin, Stella Stergiopoulos, et al.
Pageof 14